NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 318 filers reported holding NATERA INC in Q3 2023. The put-call ratio across all filers is 1.90 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $147 | -46.0% | 3,024 | -38.3% | 0.00% | -50.0% |
Q1 2023 | $272 | +724.2% | 4,899 | +502.6% | 0.00% | – |
Q4 2022 | $33 | -99.9% | 813 | +1.6% | 0.00% | – |
Q3 2022 | $35,000 | -76.8% | 800 | -81.2% | 0.00% | -100.0% |
Q2 2022 | $151,000 | -84.8% | 4,263 | -82.5% | 0.00% | -83.3% |
Q1 2022 | $993,000 | -78.2% | 24,414 | -49.9% | 0.01% | -75.0% |
Q4 2021 | $4,547,000 | -70.1% | 48,690 | -64.3% | 0.02% | -74.5% |
Q3 2021 | $15,212,000 | -10.4% | 136,505 | -8.7% | 0.09% | -13.0% |
Q2 2021 | $16,972,000 | +8260.6% | 149,494 | +7228.1% | 0.11% | +5300.0% |
Q4 2020 | $203,000 | – | 2,040 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 881,436 | $48,937,327 | 32.36% |
Kynam Capital Management, LP | 2,918,237 | $162,020,518 | 20.92% |
Sofinnova Investments, Inc. | 3,100,560 | $172,143,091 | 11.01% |
Eversept Partners, LP | 2,819,770 | $156,553,630 | 10.92% |
Eagle Health Investments LP | 784,894 | $43,577,315 | 8.48% |
Lagoda Investment Management, L.P. | 162,625 | $9,028,940 | 6.42% |
BEACONLIGHT CAPITAL, LLC | 204,567 | $11,357,560 | 6.00% |
Bain Capital Life Sciences Investors, LLC | 700,197 | $38,875 | 4.86% |
PERKINS CAPITAL MANAGEMENT INC | 62,700 | $3,481 | 3.28% |
RTW INVESTMENTS, LP | 2,611,783 | $145,006,192 | 3.02% |